Evidence map›Paper›PMID 38032118›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Rapid Prototyping of Thermoplastic Microfluidic 3D Cell Culture Devices by Creating Regional Hydrophilicity Discrepancy.

Haiqing Bai, Kristen N Peters Olson, Ming Pan, Thomas Marshall, Hardeep Singh, Jingzhe Ma, Paige Gilbride, Yu-Chieh Yuan, Jenna McCormack, Longlong Si and 6 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Deep Learning-Powered Scalable Cancer Organ Chip for Cancer Precision Medicine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Haiqing BaiXellar Biosystems, Cambridge, MA, 02458, USA.
Kristen N Peters OlsonXellar Biosystems, Cambridge, MA, 02458, USA.
Ming PanXellar Biosystems, Cambridge, MA, 02458, USA.
Thomas MarshallXellar Biosystems, Cambridge, MA, 02458, USA.
Hardeep SinghXellar Biosystems, Cambridge, MA, 02458, USA.
Jingzhe MaXellar Biosystems, Cambridge, MA, 02458, USA.
Paige GilbrideXellar Biosystems, Cambridge, MA, 02458, USA.
Yu-Chieh YuanXellar Biosystems, Cambridge, MA, 02458, USA.
Jenna McCormackXellar Biosystems, Cambridge, MA, 02458, USA.
Longlong SiCAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, P. R. China.
Sushila MaharjanDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, 02142, USA.
Di HuangResearch Center for Nano-biomaterials & Regenerative Medicine, College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan, 030024, P. R. China.
Xiaohua QianXellar Biosystems, Cambridge, MA, 02458, USA.
Carol LivermoreDepartment of Mechanical and Industrial Engineering, Northeastern University, Boston, MA, 02115, USA.
Yu Shrike ZhangDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, 02142, USA.ORCID 0000-0002-0045-0808
Xin XieXellar Biosystems, Cambridge, MA, 02458, USA.
Brigham and Women's Hospital · USChinese Academy of Sciences · CNNortheastern University · USTaiyuan University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidic 3D cell culture devices that enable the recapitulation of key aspects of organ structures and functions in vivo represent a promising preclinical platform to improve translational success during drug discovery. Essential to these engineered devices is the spatial patterning of cells from different tissue types within a confined microenvironment. Traditional fabrication strategies lack the scalability, cost-effectiveness, and rapid prototyping capabilities required for industrial applications, especially for processes involving thermoplastic materials. Here, an approach to pattern fluid guides inside microchannels is introduced by establishing differential hydrophilicity using pressure-sensitive adhesives as masks and a subsequent selective coating with a biocompatible polymer. Optimal coating conditions are identified using polyvinylpyrrolidone, which resulted in rapid and consistent hydrogel flow in both the open-chip prototype and the fully bonded device containing additional features for medium perfusion. The suitability of the device for dynamic 3D cell culture is tested by growing human hepatocytes in the device under controlled fluid flow for a 14-day period. Additionally, the study demonstrated the potential of using the device for pharmaceutical high-throughput screening applications, such as predicting drug-induced liver injury. The approach offers a facile strategy of rapid prototyping thermoplastic microfluidic organ chips with varying geometries, microstructures, and substrate materials.

Indexed as

HepatocytesMicrofluidicsCell Culture Techniques, Three DimensionalHumansHydrogelsHydrogelscoatinghydrophilicitymicrofluidicsorgan-on-a-chipthermoplastic

Identifiers

PMID38032118
PMCPMC10870023
OpenAlexW4389179614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.